These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 21747146)

  • 1. [Clostridium botulinum and botulinum neurotoxin].
    Hirai Y
    Brain Nerve; 2011 Jul; 63(7):755-61. PubMed ID: 21747146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long journey of botulinum neurotoxins into the synapse.
    Rummel A
    Toxicon; 2015 Dec; 107(Pt A):9-24. PubMed ID: 26363288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Structure and function of botulinum toxin].
    Fujii N
    Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25.
    Blasi J; Chapman ER; Link E; Binz T; Yamasaki S; De Camilli P; Südhof TC; Niemann H; Jahn R
    Nature; 1993 Sep; 365(6442):160-3. PubMed ID: 8103915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular mechanism of action of tetanus toxin and botulinum neurotoxins].
    Poulain B
    Pathol Biol (Paris); 1994 Feb; 42(2):173-82. PubMed ID: 7916455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxins: mechanisms of action, antinociception and clinical applications.
    Wheeler A; Smith HS
    Toxicology; 2013 Apr; 306():124-46. PubMed ID: 23435179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and stability of the nontoxic component of the botulinum toxin complex.
    Miyata K; Yoneyama T; Suzuki T; Kouguchi H; Inui K; Niwa K; Watanabe T; Ohyama T
    Biochem Biophys Res Commun; 2009 Jun; 384(1):126-30. PubMed ID: 19394306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.
    Yoneyama T; Miyata K; Chikai T; Mikami A; Suzuki T; Hasegawa K; Ikeda T; Watanabe T; Ohyama T; Niwa K
    FEMS Immunol Med Microbiol; 2008 Dec; 54(3):290-8. PubMed ID: 18801042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes.
    Baldwin MR; Barbieri JT
    Biochemistry; 2007 Mar; 46(11):3200-10. PubMed ID: 17311420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The action of batulinum toxin at the neuromuscular junction.
    Sellin LC
    Med Biol; 1981 Feb; 59(1):11-20. PubMed ID: 6115105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of intestinal absorption of botulinum neurotoxin complex].
    Matsumura T
    Nihon Saikingaku Zasshi; 2019; 74(3):167-175. PubMed ID: 31787706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-cell specificity and transcytosis of nontoxic nonhemagglutinin protein of botulinum neurotoxin serotype D.
    Miyashita S; Niwa K; Watanabe T; Sagane Y
    FEMS Microbiol Lett; 2014 Aug; 357(2):115-22. PubMed ID: 25041523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The structure and mechanism of action of clostridial neurotoxins].
    Parasion S; Bartoszcze M; Gryko R
    Przegl Epidemiol; 2007; 61(3):519-27. PubMed ID: 18069389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
    Agarwal R; Binz T; Swaminathan S
    Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components.
    Mutoh S; Kouguchi H; Sagane Y; Suzuki T; Hasegawa K; Watanabe T; Ohyama T
    Biochemistry; 2003 Sep; 42(37):10991-7. PubMed ID: 12974634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells.
    Niwa K; Yoneyama T; Ito H; Taira M; Chikai T; Kouguchi H; Suzuki T; Hasegawa K; Miyata K; Inui K; Ikeda T; Watanabe T; Ohyama T
    Vet Microbiol; 2010 Mar; 141(3-4):312-20. PubMed ID: 19786330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect].
    Poulain B; Humeau Y
    Ann Readapt Med Phys; 2003 Jul; 46(6):265-75. PubMed ID: 12928128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.